Treatment Efficacy Rankings

Treatment Efficacy Rankings

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Treatment Efficacy Rankings</th>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Lecanemab](/therapeutics/lecanemab)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Donanemab](/therapeutics/donanemab)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Aducanumab](/therapeutics/aducanumab)</td>
</tr>
<tr>
<td class="label">4</td>
<td>[Atabecestat](/therapeutics/atabecestat)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Donepezil](/therapeutics/donepezil)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Memantine](/therapeutics/memantine)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Rivastigmine](/therapeutics/rivastigmine)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Levodopa/Carbidopa](/therapeutics/levodopa)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Deep Brain Stimulation](/therapeutics/deep-brain-stimulation)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[ Pramipexole](/therapeutics/pramipexole)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Inosine](/therapeutics/inosine)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[GM1 ganglioside]

Treatment Efficacy Rankings

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Treatment Efficacy Rankings</th>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Lecanemab](/therapeutics/lecanemab)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Donanemab](/therapeutics/donanemab)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Aducanumab](/therapeutics/aducanumab)</td>
</tr>
<tr>
<td class="label">4</td>
<td>[Atabecestat](/therapeutics/atabecestat)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Donepezil](/therapeutics/donepezil)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Memantine](/therapeutics/memantine)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Rivastigmine](/therapeutics/rivastigmine)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Levodopa/Carbidopa](/therapeutics/levodopa)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Deep Brain Stimulation](/therapeutics/deep-brain-stimulation)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[ Pramipexole](/therapeutics/pramipexole)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Inosine](/therapeutics/inosine)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[GM1 ganglioside](/therapeutics/gm1-ganglioside)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Tofersen](/therapeutics/tofersen)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Riluzole](/therapeutics/riluzole)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Edaravone](/therapeutics/edaravone)</td>
</tr>
<tr>
<td class="label">4</td>
<td>[Relyvrio](/therapeutics/relyvrio)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>[Tetrabenazine](/therapeutics/tetrabenazine)</td>
</tr>
<tr>
<td class="label">2</td>
<td>[Deutetrabenazine](/therapeutics/deutetrabenazine)</td>
</tr>
<tr>
<td class="label">3</td>
<td>[Tominersen](/therapeutics/tominersen)</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>Structured exercise (aerobic + resistance + balance)</td>
</tr>
<tr>
<td class="label">2</td>
<td>Mediterranean/MIND diet</td>
</tr>
<tr>
<td class="label">3</td>
<td>Multidisciplinary rehabilitation (PT/OT/SLP)</td>
</tr>
<tr>
<td class="label">4</td>
<td>Rasagiline (MAO-B inhibitor)</td>
</tr>
<tr>
<td class="label">5</td>
<td>Rapamycin (mTOR inhibition)</td>
</tr>
<tr>
<td class="label">6</td>
<td>TUDCA/UDCA (bile acid therapy)</td>
</tr>
<tr>
<td class="label">7</td>
<td>Vitamin D supplementation</td>
</tr>
<tr>
<td class="label">8</td>
<td>Spermidine (autophagy induction)</td>
</tr>
<tr>
<td class="label">9</td>
<td>Photobiomodulation (PBM)</td>
</tr>
<tr>
<td class="label">10</td>
<td>Cognitive reserve/mental engagement</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">11</td>
<td>Resveratrol/SIRT1 activation</td>
</tr>
<tr>
<td class="label">12</td>
<td>Creatine supplementation</td>
</tr>
<tr>
<td class="label">13</td>
<td>Methylene Blue/LMTX</td>
</tr>
<tr>
<td class="label">14</td>
<td>Coenzyme Q10</td>
</tr>
<tr>
<td class="label">15</td>
<td>Ambroxol (GCase chaperone)</td>
</tr>
<tr>
<td class="label">16</td>
<td>Omega-3 fatty acids (DHA/EPA)</td>
</tr>
<tr>
<td class="label">17</td>
<td>Sleep optimization/apnea treatment</td>
</tr>
<tr>
<td class="label">18</td>
<td>NACET</td>
</tr>
<tr>
<td class="label">19</td>
<td>Sulforaphane/Nrf2 activation</td>
</tr>
<tr>
<td class="label">20</td>
<td>Deferiprone (iron chelation)</td>
</tr>
<tr>
<td class="label">Symptom</td>
<td>First-Line</td>
</tr>
<tr>
<td class="label">Motor/Bradykinesia</td>
<td>Levodopa (trial)</td>
</tr>
<tr>
<td class="label">Falls/Postural instability</td>
<td>Physical therapy</td>
</tr>
<tr>
<td class="label">Neck dystonia (retrocollis)</td>
<td>Botulinum toxin</td>
</tr>
<tr>
<td class="label">Depression</td>
<td>SSRIs</td>
</tr>
<tr>
<td class="label">Apathy</td>
<td>Methylphenidate</td>
</tr>
<tr>
<td class="label">Pseudobulbar affect</td>
<td>Dextromethorphan/quinidine</td>
</tr>
<tr>
<td class="label">Rank</td>
<td>Treatment</td>
</tr>
<tr>
<td class="label">1</td>
<td>Structured exercise (aerobic + resistance + balance)</td>
</tr>
<tr>
<td class="label">2</td>
<td>Mediterranean/MIND diet</td>
</tr>
<tr>
<td class="label">3</td>
<td>Multidisciplinary rehabilitation (PT/OT/SLP)</td>
</tr>
<tr>
<td class="label">4</td>
<td>Rasagiline (MAO-B inhibitor)</td>
</tr>
<tr>
<td class="label">5</td>
<td>Rapamycin (mTOR inhibition)</td>
</tr>
<tr>
<td class="label">6</td>
<td>TUDCA/UDCA (bile acid therapy)</td>
</tr>
<tr>
<td class="label">7</td>
<td>Vitamin D supplementation</td>
</tr>
<tr>
<td class="label">8</td>
<td>Spermidine (autophagy induction)</td>
</tr>
<tr>
<td class="label">9</td>
<td>Photobiomodulation (PBM)</td>
</tr>
<tr>
<td class="label">10</td>
<td>Cognitive reserve/mental engagement</td>
</tr>
<tr>
<td class="label">Symptom</td>
<td>First-Line</td>
</tr>
<tr>
<td class="label">Motor symptoms</td>
<td>Levodopa trial</td>
</tr>
<tr>
<td class="label">Dystonia</td>
<td>Botulinum toxin</td>
</tr>
<tr>
<td class="label">Myoclonus</td>
<td>Levetiracetam, clonazepam</td>
</tr>
<tr>
<td class="label">Cognitive impairment</td>
<td>Donepezil, rivastigmine</td>
</tr>
<tr>
<td class="label">Apathy</td>
<td>Methylphenidate</td>
</tr>
<tr>
<td class="label">Depression/Anxiety</td>
<td>SSRIs</td>
</tr>
<tr>
<td class="label">Treatment</td>
<td>Efficacy</td>
</tr>
<tr>
<td class="label">[Donepezil](/entities/donepezil)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Rivastigmine](/entities/rivastigmine)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Memantine</td>
<td>Modest</td>
</tr>
<tr>
<td class="label">Aducanumab</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Treatment</td>
<td>Efficacy</td>
</tr>
<tr>
<td class="label">Carbidopa/levodopa</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dopamine agonists</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">MAO-B inhibitors</td>
<td>Modest</td>
</tr>
<tr>
<td class="label">Deep brain stimulation</td>
<td>High</td>
</tr>
<tr>
<td class="label">Priority</td>
<td>Disease</td>
</tr>
<tr>
<td class="label">High</td>
<td>Parkinson's</td>
</tr>
<tr>
<td class="label">High</td>
<td>Parkinson's</td>
</tr>
<tr>
<td class="label">High</td>
<td>Parkinson's</td>
</tr>
<tr>
<td class="label">High</td>
<td>Parkinson's</td>
</tr>
<tr>
<td class="label">High</td>
<td>FTD</td>
</tr>
<tr>
<td class="label">High</td>
<td>CBS</td>
</tr>
<tr>
<td class="label">High</td>
<td>PSP</td>
</tr>
<tr>
<td class="label">Treatment</td>
<td>Current Words</td>
</tr>
<tr>
<td class="label">Ropinirole</td>
<td>6289</td>
</tr>
<tr>
<td class="label">Rotigotine</td>
<td>6620</td>
</tr>
<tr>
<td class="label">Entacapone</td>
<td>6231</td>
</tr>
</table>

Treatment Efficacy Rankings is a therapeutic approach or intervention being investigated for neurodegenerative diseases. This page reviews the scientific rationale, preclinical and clinical evidence, dosing considerations, and current status of research. [@neurowiki]

Rankings of treatments by clinical efficacy, disease modification evidence, safety profile, and clinical utility across neurodegenerative diseases.

Alzheimer's Disease Treatments

Disease-Modifying Therapies (DMTs)

Symptomatic Therapies

Parkinson's Disease Treatments

Motor Symptoms

Disease-Modifying Candidates

ALS Treatments

Huntington's Disease

Progressive Supranuclear Palsy (PSP) Treatments

PSP is a 4R-tauopathy with no FDA-approved disease-modifying therapies. Treatment focuses on symptomatic management, neuroprotection, and rehabilitation. See the [PSP Treatment](/therapeutics/progressive-supranuclear-psp-psp-treatment) page for detailed protocols and the [CBS/PSP Treatment Rankings](/therapeutics/cbs-psp-treatment-rankings) for evidence-scored interventions.

Tier 1: Strong Evidence Interventions

Tier 2: Moderate Evidence

Key Symptomatic Treatments

Emerging Disease-Modifying Approaches

• Tideglusib (GSK-3β inhibitor): Phase 2 completed[^39]
• Rapamycin: mTOR inhibition for autophagy
• ApoE-targeted therapies: Genetic subset considerations

Corticobasal Syndrome (CBS) Treatments

CBS presents unique challenges due to heterogeneous pathology. Like PSP, no disease-modifying therapies exist. Treatment is symptomatic and rehabilitative. See the [CBS Treatment](/therapeutics/corticobasal-cbs-treatment) page for detailed protocols.

Tier 1: Strong Evidence Interventions

Key Symptomatic Treatments

Disease-Modifying Pipeline

• Tau immunotherapies: Gantenerumab, semorinemab (failed in CBS)
• Tideglusib: GSK-3β inhibitor (Phase 2)[^39]
• Lithium: Low-dose (Phase 2)[^30]

Efficacy Metrics

Clinical Outcome Measures

• ADAS-Cog: Alzheimer's cognition (0-70)
• MDS-UPDRS: Parkinson's motor (0-132)
• ALSFRS-R: ALS function (0-48)
• UHDRS: Huntington's (0-400)

Biomarker Correlates

• Amyloid PET SUVr reduction
• CSF p-[tau](/proteins/tau)/t-tau ratio
• Volumetric MRI loss rate

Safety Rankings

Best Tolerability

Notable Safety Concerns

• ARIA (brain edema/hemorrhage): Aducanumab, [Lecanemab](/entities/lecanemab), [Donanemab](/entities/donanemab)
• Liver toxicity: Many Phase 1 compounds
• Cardiac: Some dopamine agonists

Symptomatic Treatment Rankings

Cognitive Symptoms

Motor Symptoms (PD)

Disease-Modifying Therapy Rankings

By Mechanism Validation

By Development Progress

• Advanced (Phase 3+): Lecanemab, Donanemab, Inosine
• Mid-stage (Phase 2): TREM2 agonists, gene therapies
• Early (Phase 1): Novel small molecules, cell therapies

Related Pages

• [Treatment Pipeline Overview](/treatment-pipeline-overview)
• [Drug Target Landscape](/drug-target-landscape)
• [Protein Drug Targets](/proteins/protein-drug-targets)
• [Therapeutic Targetability](/mechanisms/_therapeutic-targets)

Coverage Gaps and Needs Work

This section identifies missing or underdeveloped treatment pages that need coverage.

Critical Treatment Gaps

The following treatments have no dedicated pages but are important for neurodegenerative disease management:

Underdeveloped Existing Pages

Some treatment pages exist but need expansion:

Task Recommendations

Based on this analysis, the following tasks should be created:

See Also

• [Lecanemab](/clinical-trials/lecanemab-clarity-ad)
• [Donanemab](/clinical-trials/nct05738486)
• [Aducanumab](/therapeutics/aducanumab)
• [Atabecestat](/mechanisms/dopaminergic-neuron-vulnerability)
• [Donepezil](/entities/donepezil)
• [Memantine](/therapeutics/memantine)
• [Rivastigmine](/entities/rivastigmine)
• [Levodopa/Carbidopa](/therapeutics/carbidopa)
• [Deep Brain Stimulation](/technologies/deep-brain-stimulation)
• [Pramipexole](/clinical-trials/pramipexole-early-pd)